SCHEMBL18197862

SCHEMBL18197862

Oc1ccc(Cc2nnc3cccnn23)cc1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18197871 0.85 MET (0.47) MET
SCHEMBL18197866 0.80 ALDH1A1 (0.47) MET
SCHEMBL18197867 0.79 POLB (0.48) MET
SCHEMBL2497393 0.77 MET (0.56) MET
SCHEMBL5229478 0.75 MET (1.00) MET
SCHEMBL18197849 0.75 MET (0.70) MET
SCHEMBL2269214 0.74 MET (0.63) MET
SCHEMBL2495255 0.74 MET (1.00) MET
SCHEMBL18197888 0.74 MET (0.41) MET
SCHEMBL18197881 0.74 MET (0.55) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966214-B9 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-09-13 EP disclosed
EP-1966214-B1 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-11-02 EP disclosed